Biosimilars Analysis
🇪🇺 EMAExpert commentary and market intelligence for pharma strategy teams
Showing 1–7 of 7 articles
Earlier
Medium impact AnalysisMay 31, 2026
Global Biosimilar Market Analysis: Trends and Challenges
3 min
Dr. Elena RossiMedium impact AnalysisMay 30, 2026
From Promise to Proof: The Shakeup in Today’s Biosimilar Market
3 min
Dr. Elena RossiStandard impact AnalysisMay 2, 2026
Biosimilar Uptake EU: Market Impact Post-Patent Expirations & HTA Regulation
EMA · biologics · 9 min
Dr. Emily CarterMedium impact AnalysisApr 29, 2026
Biosimilars Growth in EU: Market Forecast Post-Biologics Patent Expiry
EMA · Oncology · 9 min
Dr. Priya NandakumarStandard impact AnalysisApr 29, 2026
Biosimilar Oncology Antibodies: EMA Market Dynamics & Healthcare Impact
EMA · oncology · 12 min
Dr. Grace TanHigh impact AnalysisApr 21, 2026
EU Pharmaceutical Legislation Reform: Impact on Generic and Biosimilar Markets 2026-27
EMA · Pharmaceutical Market · 4 min
Dr. Elena RossiStandard impact AnalysisApr 20, 2026
EMA Decision on Biosimilar Pricing: Key Insights for Oncology Market
EMA · Oncology · 10 min
Dr. Elena RossiExplore intelligence